Christopher P. Lowe, Chief Financial Officer & CBO at Anthera Pharmaceuticals Inc (ANTH), sold 15,000 shares at $6.88 ($103K) on 2011-11-03, disclosed to the SEC on 2011-11-04.
Scheduled sale ($103k) by Chief Financial Officer & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRTX | SELL | 2021-08-18 | $4.1M | — | Filing → |
| CRTX | SELL | 2021-06-30 | $2.2M | — | Filing → |
| VINC | BUY | 2021-06-30 | $126K | — | Filing → |